MBA Early Feasibility Study
NCT: NCT07564375 · NOT_YET_RECRUITING
NCT IDNCT07564375
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2034-11
Brief Summary
The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device through five years following the index endovascular procedure.
Frequently Asked Questions
What is MBA Early Feasibility Study?
MBA Early Feasibility Study is a clinical trial registered under NCT07564375. Current status: NOT_YET_RECRUITING.
What is the status of NCT07564375?
The current status of NCT07564375 (MBA Early Feasibility Study) is: NOT_YET_RECRUITING.
When did MBA Early Feasibility Study start?
MBA Early Feasibility Study started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.